Recurrent Episodes of Hypokalaemia during Treatment with Inhaled Beta-2 Agonist Revealing Gitelman Syndrome, an Uncommon Clinical Entity

A 28-year-old female patient was hospitalized for mild–moderate hypokalaemia which was persistent despite discontinuation of beta-2 agonist bronchodilator treatment. Her past medical history was relevant for two episodes of severe hypokalaemia after active inhaled beta-2 agonist treatment for asthma...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of case reports in internal medicine Vol. 9; no. 10; p. 003605
Main Authors:	Sablón-González, Nery, Parodis-Lopez, Yanet, Alonso-Ortiz, Maria Belen, Laurin, Angélica, Andres, Emmanuel, Lorenzo Villalba, Noel
Format:	Journal Article
Language:	English
Published:	SMC Media Srl 20-10-2022 SMC MEDIA SRL
Subjects:	gitelman syndrome hypokalemia metabolic alcalosis
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	A 28-year-old female patient was hospitalized for mild–moderate hypokalaemia which was persistent despite discontinuation of beta-2 agonist bronchodilator treatment. Her past medical history was relevant for two episodes of severe hypokalaemia after active inhaled beta-2 agonist treatment for asthma crisis. Investigations revealed increased potassium in spot urine with a transtubular potassium gradient <4. A 24-hour urine analysis showed hypophosphaturia, hypocalciuria, hypomagnesuria and normal urine prostaglandins in favour of Gitelman syndrome. Oral potassium supplementation was started and genetic studies were recommended.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2284-2594 2284-2594
DOI:	10.12890/2022_003605